Basal Cell Carcinoma: Advances in Treatment and Research
Editat de Michael R. Migden, Leon Chen, Sirunya Silapunten Limba Engleză Paperback – 9 ian 2021
Meant for a multi-disciplinary audience of dermatologists, Mohs Surgeons, oncologists, head and neck surgeons, oculoplastic surgeons, radiation oncologists, this book serves as an informative practical guide for physicians, mid-level providers and trainees. Basal Cell Carcinoma, is edited and written by leaders with expertise in cutaneous oncology, pathology, dermatology, Mohs micrographic surgery, plastic surgery, and many more specialties.
| Toate formatele și edițiile | Preț | Express |
|---|---|---|
| Paperback (1) | 558.56 lei 38-44 zile | |
| Springer International Publishing – 9 ian 2021 | 558.56 lei 38-44 zile | |
| Hardback (1) | 829.87 lei 3-5 săpt. | |
| Springer International Publishing – 19 dec 2019 | 829.87 lei 3-5 săpt. |
Preț: 558.56 lei
Preț vechi: 587.96 lei
-5% Nou
Puncte Express: 838
Preț estimativ în valută:
106.90€ • 111.04$ • 88.79£
106.90€ • 111.04$ • 88.79£
Carte tipărită la comandă
Livrare economică 30 ianuarie-05 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783030268893
ISBN-10: 3030268896
Pagini: 290
Ilustrații: XIV, 290 p. 78 illus., 72 illus. in color.
Dimensiuni: 155 x 235 mm
Greutate: 0.44 kg
Ediția:1st ed. 2020
Editura: Springer International Publishing
Colecția Springer
Locul publicării:Cham, Switzerland
ISBN-10: 3030268896
Pagini: 290
Ilustrații: XIV, 290 p. 78 illus., 72 illus. in color.
Dimensiuni: 155 x 235 mm
Greutate: 0.44 kg
Ediția:1st ed. 2020
Editura: Springer International Publishing
Colecția Springer
Locul publicării:Cham, Switzerland
Cuprins
Chapter 1. Epidemiology and Risk Factors of Basal Cell Carcinoma.- Chapter 2. Pathophysiology of Basal Cell Carcinoma and Its Associated Genetic Syndromes.- Chapter 3. Histopathology of Basal Cell Carcinoma and Its Variants.- Chapter 4. Topical Therapy for the Treatment of Basal Cell Carcinoma.- Chapter 5. Local Immunotherapy for Basal Cell Carcinoma with Interferon.- Chapter 6. Cryotherapy and Electrodesiccation & Curettage for Basal Cell Carcinoma.- Chapter 7. Mohs Micrographic Surgery for the Treatment of Basal Cell Carcinoma.- Chapter 8. Surgical Treatment for Basal Cell Carcinoma of the Head and Neck.- Chapter 9. Special Considerations for Periocular Basal Cell Carcinoma.- Chapter 10. Radiotherapy for Basal Cell Carcinoma.- Chapter 11. Photodynamic Therapy for the Treatment of Basal Cell Carcinoma.- Chapter 12. Laser Therapy for the Treatment of Basal Cell Carcinoma.- Chapter 13. Hedgehog Signaling Pathway Inhibitors for Basal Cell Carcinoma.- Chapter 14. Immunotherapy for Basal Cell Carcinoma.- Chapter 15. Treatment: Future Directions.
Notă biografică
Michael R. Migden, MD
Academic Affiliation:
Departments of Dermatology and Head and Neck Surgery
The University of Texas MD Anderson Cancer Center
Houston, TX, USA
Dr. Migden, professor, departments of dermatology and head and neck surgery at MD Anderson Cancer Center, specializes in Mohs micrographic surgery, complex reconstruction, and clinical research in cutaneous oncology. He is the principal investigator of various clinical trials that evaluate the use of hedgehog pathway inhibitors and immunotherapy for advanced nonmelanoma skin cancer, devices for detection of cutaneous malignancy and methods for documenting skin biopsy site location for treatment. His research has been published in the New England Journal of Medicine, Lancet Oncology, and other high impact peer-reviewed journals. Dr. Migden is the author of multiple book chapters and speaks nationally and internationally on cutaneous reconstruction, hedgehog pathway inhibitors, immunotherapy therapy, and the use of digital media in surgical education.
Dr. Migden, professor, departments of dermatology and head and neck surgery at MD Anderson Cancer Center, specializes in Mohs micrographic surgery, complex reconstruction, and clinical research in cutaneous oncology. He is the principal investigator of various clinical trials that evaluate the use of hedgehog pathway inhibitors and immunotherapy for advanced nonmelanoma skin cancer, devices for detection of cutaneous malignancy and methods for documenting skin biopsy site location for treatment. His research has been published in the New England Journal of Medicine, Lancet Oncology, and other high impact peer-reviewed journals. Dr. Migden is the author of multiple book chapters and speaks nationally and internationally on cutaneous reconstruction, hedgehog pathway inhibitors, immunotherapy therapy, and the use of digital media in surgical education.
Leon Chen, MD
Academic Affiliation:
Department of Dermatology
The University of Texas McGovern Medical School at Houston,
Houston, Texas, USA
Department of Dermatology
The University of Texas MD Anderson Cancer Center
Houston, TX, USA
Dr. Chen received his medical degree from the University of Texas McGovern Medical School at Houston and continued his fellowship training for Micrographic Surgery and Dermatologic Oncology (Mohs) at MD Anderson Cancer Center after completing dermatology residency at the MD Anderson Cancer Center/University of Texas McGovern Medical School combined program. Dr. Chen’s deep passion for cutaneous oncology has led him to author numerous research manuscripts, and his research has been presented at national and international dermatology meetings. His clinical interests include treating skin cancers with both surgical and non-surgical modalities.
Sirunya Silapunt, MD
Academic Affiliation:
Department of Dermatology
The University of Texas McGovern Medical School at Houston,
Houston, Texas, USA
Dr. Silapunt is a board-certified dermatologist and currently serves as an associate professor of the Department of Dermatology at The University of Texas McGovern Medical School at Houston. She is a faculty in Micrographic Surgery & Dermatologic Oncology Fellowship Program, clinical associate professor at MD Anderson Cancer Center, and an associate program director for the American Society of Dermatologic Surgery (ASDS) Cosmetic Dermatologic Surgery Fellowship Accreditation Program. Dr. Silapunt treats a wide variety of skin conditions and a large part of her practice consists of skin cancer and varicose vein treatments. Dr. Silapunt also has aspecial focus in laser and cosmetic dermatology. Dr. Silapunt has authored more than 50 peer-reviewed research manuscripts and numerous book chapters. She is an editor of the textbook “Treatment of Leg Veins, 2nd edition”. Dr. Silapunt’s academic achievement and expertise in the field of dermatology have made her an invited speaker at various national and international conferences.
Dr. Silapunt is a board-certified dermatologist and currently serves as an associate professor of the Department of Dermatology at The University of Texas McGovern Medical School at Houston. She is a faculty in Micrographic Surgery & Dermatologic Oncology Fellowship Program, clinical associate professor at MD Anderson Cancer Center, and an associate program director for the American Society of Dermatologic Surgery (ASDS) Cosmetic Dermatologic Surgery Fellowship Accreditation Program. Dr. Silapunt treats a wide variety of skin conditions and a large part of her practice consists of skin cancer and varicose vein treatments. Dr. Silapunt also has aspecial focus in laser and cosmetic dermatology. Dr. Silapunt has authored more than 50 peer-reviewed research manuscripts and numerous book chapters. She is an editor of the textbook “Treatment of Leg Veins, 2nd edition”. Dr. Silapunt’s academic achievement and expertise in the field of dermatology have made her an invited speaker at various national and international conferences.
Textul de pe ultima copertă
Basal Cell Carcinoma: Advances in Treatment and Research, edited and written by leaders with expertise in cutaneous oncology, dermatopathology, dermatology, Mohs micrographic surgery, head and neck surgery, oculoplastic surgery and radiation oncology, provides a comprehensive overview of evidence-based treatment approaches for the most common cancer worldwide - basal cell carcinoma. The first part of this book details the epidemiology, risk factors, pathophysiology, and different histologic subtypes of basal cell carcinoma highlighted with high-resolution histopathology images. The second part of the book provides an in-depth review of different treatment modalities including topical therapy, local immunotherapy with interferon, cryotherapy, electrodesiccation and curettage, radiotherapy, and surgical approaches with Mohs micrographic surgery, head and neck surgery, and oculoplastic surgery. The final part of book highlights the utilization of innovative technology such as photodynamic therapy and laser for the treatment of basal cell carcinoma as well as emerging systemic therapeutic options including hedgehog pathway inhibitors and immunotherapy for the difficult-to-treat disease state, advanced basal cell carcinoma.
Meant for a multi-disciplinary audience of dermatologists, Mohs Surgeons, oncologists, head and neck surgeons, oculoplastic surgeons, radiation oncologists, this book serves as an informative practical guide for physicians, mid-level providers and trainees.
Meant for a multi-disciplinary audience of dermatologists, Mohs Surgeons, oncologists, head and neck surgeons, oculoplastic surgeons, radiation oncologists, this book serves as an informative practical guide for physicians, mid-level providers and trainees.
Caracteristici
Comprehensive overview of evidence-based treatment for basal cell carcinoma Ordered into three parts for ease of use Featuring high-resolution histopathology images Multi-disciplinary readership